Shed vs RxActivate: Coaching and Pricing Transparency Compared
Quick verdict: For patients who want integrated coaching plus a choice of name-brand or compounded GLP-1, Shed stands out; for those who prefer clinician-matched plans but will share contact details before seeing price, RxActivate is an alternative. This article compares Shed vs RxActivate across pricing transparency, medication options, assessment flow, coaching, and eligibility.
Explore Shed options and start the 2-minute assessment
Side-by-side summary: core differences
Shed offers both FDA-approved name-brand options and compounded GLP-1 alongside continuous coaching, a 2-minute approval assessment and 10% off your first month. RxActivate uses a two-minute eligibility questionnaire and clinician-matched GLP-1 plans, but pricing and plan details are gated behind a contact-information step; Alabama service availability was confirmed in a synthetic test.
Key distinctions to consider
1. Pricing transparency and gating
Shed publishes specific starting prices for compounded options: compounded semaglutide injections starting at $199/month and compounded tirzepatide injections starting at $299/month, and advertises Get 10% Off your First Month. Shed also notes that name-brand options carry significantly higher costs. By contrast, RxActivate requires first name, last name, email and phone number before revealing any plan or price; no price, medication fee, membership fee, shipping charge, cancellation term or billing commitment was displayed before the contact-information gate.
Start RxActivate eligibility questionnaire
2. Medication options and regulatory notes
Shed explicitly offers both name-brand FDA-approved GLP-1 medications and compounded alternatives on one platform, and states that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription. RxActivate presents clinician-matched GLP-1 plans and notes that medication-specific approval status must be confirmed; it also states that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Neither provider makes branded and compounded products interchangeable without confirmation.
3. Coaching and care model
Shed emphasizes continuous coaching integrated into treatment and positions coaching as part of the monthly cost rather than a separate add-on. The platform says coaching supports titration, lifestyle changes and plateaus. RxActivate focuses on clinician-matched plans and medical safety screening rather than an explicit coaching program in the captured evidence.
4. Assessment flow and speed
Shed advertises a 2-minute approval assessment to check eligibility quickly, after which a clinician reviews the case and a prescription is issued if appropriate. RxActivate uses a two-minute eligibility questionnaire that requests goals, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening; RxActivate displayed likely eligibility in the flow but required contact details before revealing plans or price.
Comparison table
| Criteria | Shed | RxActivate |
|---|---|---|
| Pricing transparency | Compounded semaglutide starting at $199/month; compounded tirzepatide starting at $299/month; 10% off first month | Pricing gated; no price displayed before contact-information step |
| Medication options | Name-brand and compounded GLP-1 options on one platform | Clinician-matched GLP-1 plans; medication-specific approval must be confirmed |
| Coaching or care model | Continuous coaching integrated into treatment | Clinician-matched plan and medical-safety screening reported; coaching not specified in captured evidence |
| Assessment speed | 2-minute approval assessment with clinician review | Two-minute eligibility questionnaire; contact info required before prices |
| State availability / testing | Availability determined after clinician review; treatment only when medically appropriate | Alabama service availability confirmed in synthetic test; eligibility and state screening included |
Practical implications of the differences
If you want upfront price context and a program that bundles coaching with medication selection, Shed supplies starting price indications for compounded products, a coaching-first model and an advertised 2-minute assessment. If you prioritize clinician-matched plans and are willing to provide contact information before seeing cost, RxActivate emphasizes eligibility screening and matched plans; its flow displayed likely eligibility but withheld pricing until contact details were entered.
See Shed membership and medication options
Complete RxActivate questionnaire
Begin Shed 2-minute approval assessment
Conclusion: final guidance on Shed vs RxActivate
Both platforms require clinician review and note that treatment is available only when a licensed clinician determines it is medically appropriate. Compounded medications offered by either provider are not FDA-approved. Choose based on whether you value coaching and visible starting prices or a clinician-matched flow with gated pricing.
Choose Shed if you want an integrated coaching program plus the option to select name-brand or compounded GLP-1 with disclosed starting prices for compounded injections and 10% off your first month.
Choose RxActivate if you prefer clinician-matched GLP-1 plans and are prepared to provide contact information to see plan details, noting that pricing and specific fees are not shown before the contact-information gate.
Primary keyword: Shed vs RxActivate